Results 191 to 200 of about 5,574 (244)

Clinical and Real-World Evidence on Etanercept Biosimilar Switching: A Narrative Literature Review of Efficacy and Safety. [PDF]

Adv Ther
Schmalzing M, Askari A, Girolomoni G, Perez-Coleman JCV, Salvati C, Bachinskaya E.   +5 more
europepmc   +1 more source

Continuous Manufacturing of Recombinant Drugs: Comprehensive Analysis of Cost Reduction Strategies, Regulatory Pathways, and Global Implementation. [PDF]

Pharmaceuticals (Basel)
Niazi SK.
europepmc   +1 more source

Ensuring Sustainability in Pharmaceutical Care: A Retrospective Analysis of Administrative Databases on the Utilization, Costs, and Switching Patterns of Biological Therapies in the Agency for Health Protection of the Metropolitan Area of Milan. [PDF]

Pharmaceuticals (Basel)
Langfelder RMB, Langella R, D'Angelo C, Panico C, Cattaneo S.   +4 more
europepmc   +1 more source

Effect of liraglutide biosimilar vs. reference liraglutide on weight reduction in T2DM patients with obesity: post hoc analysis of phase III trial. [PDF]

Cardiovasc Diabetol Endocrinol Rep
Ghosh S, Sethi B, Kalra S, Baruah MP, Mane A, Choudhari S, Petare A, Jadhav M, Patil S, Barkate H.   +9 more
europepmc   +1 more source

Assessing the Comparability of Degradation Profiles Between Biosimilar and Originator Anti-VEGF Monoclonal Antibodies Under Thermal Stress. [PDF]

Pharmaceuticals (Basel)
Pamukcu C, Atik AE.
europepmc   +1 more source

Scoping review of biosimilar disease-modifying antirheumatic drugs in pregnancy: evidence gaps and proposed outcome reporting framework. [PDF]

Rheumatol Int
Cheng V, Amiri N, Cheng V, Ellis U, Cragg JJ, Proulx L, Tucker DR, De Vera MA.   +7 more
europepmc   +1 more source

Development of Biosimilar Aflibercept SDZ-AFL. [PDF]

Curr Ther Res Clin Exp
Dodeller F, Alliger P, Heyn J, Urosevic D, Allmannsberger L, Wersig C, Silva R.   +6 more
europepmc   +1 more source

Analytical Data and Single-Dose PK are Sufficient to Conclude Comparable Immunogenicity for Biosimilars: An Ustekinumab Case Study. [PDF]

BioDrugs
Schiestl M, Roy N, Trieb M, Park JP, Guillen E, Woollett G, Wolff-Holz E.   +6 more
europepmc   +1 more source

Randomised, double-masked trial to compare the efficacy, safety and immunogenicity of the biosimilar aflibercept FYB203 with reference aflibercept in patients with neovascular age-related macular degeneration. [PDF]

BMJ Open Ophthalmol
Balser S, Capsius B, Hole R, Papp A, Preissinger N, Rozenknop A, Tiko T.   +6 more
europepmc   +1 more source

State Substitution Laws and Uptake of an Interchangeable Insulin Biosimilar.

JAMA Health Forum
Kwon Y, Sarpatwari A, Dusetzina SB.
europepmc   +1 more source